GSK’s measles vaccine now approved for use in U.S.
The U.S. Food and Drug Administration (FDA) has approved an MMR vaccine developed by GlaxoSmithKline for use in America for those above the age of one.
Read More
GlaxoSmithKline
Duke Energy, GSK, responding to new letters, proposals, from Elliott
Duke Energy and GSK are responding to recent letters sent by Elliott, a fund manager that describes its tactics as “an opportunistic trading approach, the creation – not just the identification – of value.”
Read More
GSK to sell $392M of Innovia stock, says it will invest in strategic priorities
To invest in other strategic priorities, GSK will sell approximately $392 million of common stock in Innovia,the company said Thursday.
Read More
GSK and Pfizer officially merge healthcare businesses
The new company is expected to have combined sales of $12.7 billion a year.
Read More
TechWire week in review: Gigabit cities, media layoffs, IBM earnings & more
Here is a rewind of the past week’s headlines as reported by WRAL TechWire.
Read More
RTP companies are taking steps to increase diversity
A growing number of companies – both big and small, based out of the Triangle – are taking steps, in their own ways, to increase diversity. Find out more here.
Read MoreGSK acquiring Novartis consumer healthcare division for $13B
GlaxoSmithKline is acquiring the Novartis f consumer healthcare division for $13 billion. The purchase gives Glaxo full control of products that include Voltaren for muscle pain, Senosdyne toothpaste, Panadol for headaches and other Novartis products.
Read More
